Gene amplification mechanisms

Advances in Experimental Medicine and Biology

Volumn 570, Issue , 2005, Pages 343-361

  Debatisse, Michelle ^a   Malfoy, Bernard ^a  

^a INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BREAKAGE FUSION BRIDGE CYCLE; CANCER; CANCER CELL; CELL CYCLE; GENE AMPLIFICATION; GENE SEGREGATION; HUMAN; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 34548680284     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/1-4020-3764-3_12     Document Type: Review

References (107)

1. Albertson, D.G. 2003. Profiling breast cancer by array CGH. Breast Cancer Res Treat. 78:289-98.
2. Alt, F., R. Kellems, J.R. Bertino, and R.T. Schimke. 1978. Selective multiplications of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells. Journal of Biological Chemistry. 253:1357-1370.
3. Arlt, M.F., A.M. Casper, and T.W. Glover. 2003. Common fragile sites. Cytogenet Genome Res. 100:92-100.
4. Arlt, M.F., B. Xu, S.G. Durkin, A.M. Casper, M.B. Kastan, and T.W. Glover. 2004. BRCA1 is required for common-fragile-site stability via its G2/M checkpoint function. Mol Cell Biol. 24:6701-9.
5. Artandi, S.E., S. Alson, M.K. Tietze, N.E. Sharpless, S. Ye, R.A. Greenberg, D.H. Castrillon, J.W. Horner, S.R. Weiler, R.D. Carrasco, and R.A. DePinho. 2002. Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci U S A. 99:8191-6.
6. Balaban-Mallenbaum, G., G. Grove, and F.W. Gilbert. 1981. The proposed origin of double minutes from homogeneously staining regions (HSR)-marker chromosomes in human neuroblastoma hybrid cell lines. Cancer Genet. Cytogenet. 2:339-348.
7. Bassing, C.H., and F.W. Alt. 2004. H2AX may function as an anchor to hold broken chromosomal DNA ends in close proximity. Cell Cycle. 3:149-53.
8. Bassing, C.H., H. Suh, D.O. Ferguson, K.F. Chua, J. Manis, M. Eckersdorff, M. Gleason, R. Bronson, C. Lee, and F.W. Alt. 2003. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumours. Cell. 114:359-70.
9. Bernardino, J., F. Apiou, M. Gerbault-Seureau, B. Malfoy, and B. Dutrillaux. 1998. Characterization of recurrent homogeneously staining regions in 72 breast cancers. Genes Chromosomes and Cancer. 23:100-108.
10. Biedler, J.L., and B.A. Spengler. 1976. Metaphase chromosome anomaly: association with drug resistance and cell-specific products. Science. 191:185-187.
11. Brison, O. 1993. Gene amplification and tumour progression. Biochim. Biophys. Acta. 1155:25-41.
12. Canute, G.W., S.L. Longo, J.A. Longo, M.M. Shetler, T.E. Coyle, J.A. Winfield, and P.J. Hahn. 1998. The hydroxyurea-induced loss of double-minute chromosomes containing amplified epidermal growth factor receptor genes reduces the tumorigenicity and growth of human glioblastoma multiforme. Neurosurgery. 42:609-16.
13. Carroll, S.M., M.L. DeRose, P. Gaudray, C.M. Moore, D.R. Needham-Vandevanter, D.D. Von Hoff, and G.M. Wahl. 1988. Double minute chromosomes can be produced from precursors derived from a chromosomal deletion. Mol. Cell. Biol. 8:1525-1533.
14. Carroll, S.M., P. Gaudray, M.L. DeRose, J.F. Emery, J.L. Meinkoth, E. Nakkim, M. Subler, D.D. VonHoff, and G.M. Wahl. 1987. Characterization of an episome produced in hamster cells that amplify a transfected CAD gene at high frequency: functional evidence for a mammalian replication origin. Molecular and Cellular Biology. 7:1740-1750.
15. Casper, A.M., S.G. Durkin, M.F. Arlt, and T.W. Glover. 2004. Chromosomal Instability at Common Fragile Sites in Seckel Syndrome. Am J Hum Genet. 75.
16. Casper, A.M., P. Nghiem, M.F. Arlt, and T.W. Glover. 2002. ATR regulates fragile site stability. Cell. 111:779-89.
17. Celeste, A., S. Difilippantonio, M.J. Difilippantonio, O. Fernandez-Capetillo, D.R. Pilch, O.A. Sedelnikova, M. Eckhaus, T. Ried, W.M. Bonner, and A. Nussenzweig. 2003. H2AX haploinsufficiency modifies genomic stability and tumour susceptibility. Cell. 114:371-83.
18. Cha, R.S., and N. Kleckner. 2002. ATR homolog Mec1 promotes fork progression, thus averting breaks in replication slow zones. Science. 297:602-6.
19. Chernova, O.B., M.V. Chernov, Y. Ishizaka, M.L. Agarwal, and G.R. Stark. 1998. MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L- aspartate-treated cells, permitting CAD gene amplification. Mol Cell Biol. 18:536-45.
20. Chin, K., C.O. de Solorzano, D. Knowles, A. Jones, W. Chou, E.G. Rodriguez, W.L. Kuo, B.M. Ljung, K. Chew, K. Myambo, M. Miranda, S. Krig, J. Garbe, M. Stampfer, P. Yaswen, J.W. Gray, and S.J. Lockett. 2004. In situ analyses of genome instability in breast cancer. Nat Genet. 36:984-8.
21. Ciullo, M., M.A. Debily, L. Rozier, M. Autiero, A. Billault, V. Mayau, S. El Marhomy, J. Guardiola, A. Bernheim, P. Coullin, D. Piatier-Tonneau, and M. Debatisse. 2002. Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: the model of PIP gene duplication from a break at FRA7I. Hum Mol Genet. 11:2887-94.
22. Coquelle, A., E. Pipiras, F. Toledo, G. Buttin, and M. Debatisse. 1997. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell. 89:215-25.
23. Coquelle, A., L. Rozier, B. Dutrillaux, and M. Debatisse. 2002. Induction of multiple doublestrand breaks within an hsr by meganucleaseI-SceI expression or fragile site activation leads to formation of double minutes and other chromosomal rearrangements. Oncogene. 21:7671-9.
24. Coquelle, A., F. Toledo, S. Stern, A. Bieth, and M. Debatisse. 1998. A new role for hypoxia in tumour progression: induction of fragile sites triggering genomic rearrangements and formation of complex DMs and HSRs. Mol. Cell. 2:259-265.
25. Corvi, R., L. Savelyeva, L. Amler, R. Handgretinger, and M. Schwab. 1995. Cytogenetic evolution of MYCN and MDM2 amplification in the neuroblastoma LS tumour and its cell line. Eur. J. Cancer. 31A:520-3.
26. Cowell, J.K. 1982. Double minutes and homogeneously staining regions : gene amplification in mammalian cells. Ann. Rev. Genet. 16:21-59.
27. Deng, Z., L. Lezina, C.J. Chen, S. Shtivelband, W. So, and P.M. Lieberman. 2002. Telomeric proteins regulate episomal maintenance of Epstein-Barr virus origin of plasmid replication. Mol Cell. 9:493-503.
28. der-Sarkissian, H., S. Bacchetti, L. Cazes, and J.A. Londono-Vallejo. 2004. The shortest telomeres drive karyotype evolution in transformed cells. Oncogene. 23:1221-8.
29. Difilippantonio, M.J., S. Petersen, H.T. Chen, R. Johnson, M. Jasin, R. Kanaar, T. Ried, and A. Nussenzweig. 2002. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J Exp Med. 196:469-80.
30. Dujon, B. 1989. Group I introns as mobile genetic elements: facts and mechanistic speculations-a review. Gene. 82:91-114.
31. Fernandez-Capetillo, O., A. Celeste, and A. Nussenzweig. 2003. Focusing on foci: H2AX and the recruitment of DNA damage response factors. Cell Cycle. 2:426-7.
32. Fukumoto, M., A. Suzuki, J. Inazawa, T. Yoshimura, S.Arao, T. Takahashi, H. Nomura, and H. Hiai. 1993. Chromosomal location and structure of amplicons in two human cell lines with coamplification of c-myc and Ki-ras oncogenes. Somatic Cell Mol. Genet. 19:21-28.
33. Gisselsson, D. 2003. Chromosome instability in cancer: how, when, and why? Adv Cancer Res. 87:1-29.
34. Gisselsson, D., L. Gorunova, M. Hoglund, N. Mandahl, and P. Elfving. 2004. Telomere shortening and mitotic dysfunction generate cytogenetic heterogeneity in a subgroup of renal cell carcinomas. Br J Cancer. 91:327-32.
35. Gisselsson, D., L. Pettersson, M. Hoglund, M. Heidenblad, L. Gorunova, J. Wiegant, F. Mertens, P. Dal Cin, F. Mitelman, and N. Mandahl. 2000. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci U S A. 97:5357-62.
36. Gladdy, R.A., M.D. Taylor, C.J. Williams, I. Grandal, J. Karaskova, J.A. Squire, J.T. Rutka, C.J. Guidos, and J.S. Danska. 2003. The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient mice. Cancer Cell. 3:37-50.
37. Graux, C., J. Cools, C. Melotte, H. Quentmeier, A. Ferrando, R. Levine, J.R. Vermeesch, M. Stul, B. Dutta, N. Boeckx, A. Bosly, P. Heimann, A. Uyttebroeck, N. Mentens, R. Somers, R.A. MacLeod, H.G. Drexler, A.T. Look, D.G. Gilliland, L. Michaux, P. Vandenberghe, I. Wlodarska, P. Marynen, and A. Hagemeijer. 2004. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet. 36:1084-9.
38. Hammond, E.M., M.J. Dorie, and A.J. Giaccia. 2004. Inhibition of ATR leads to increased sensitivity to hypoxia/reoxygenation. Cancer Res. 64:6556-62.
39. Hellman, A., A. Rahat, S.W. Scherer, A. Darvasi, L.C. Tsui, and B. Kerem. 2000. Replication delay along FRA7H, a common fragile site on human chromosome 7, leads to chromosomal instability. Mol Cell Biol. 20:4420-7.
40. Hellman, A., E. Zlotorynski, S.W. Scherer, J. Cheung, J.B. Vincent, D.I. Smith, L. Trakhtenbrot, and B. Kerem. 2002. A role for common fragile site induction in amplification of human oncogenes. Cancer Cell. 1:89-97.
41. Hodgson, J.G., K. Chin, C. Collins, and J.W. Gray. 2003. Genome amplification of chromosome 20 in breast cancer. Breast Cancer Res Treat. 78:337-45.
42. Hoglund, M., D. Gisselsson, G.B. Hansen, T. Sall, and F. Mitelman. 2003. Ovarian carcinoma develops through multiple modes of chromosomal evolution. Cancer Res. 63:3378-85.
43. Ilves, I., S. Kivi, and M. Ustav. 1999. Long-term episomal maintenance of bovine papillomavirus type 1 plasmids is determined by attachment to host chromosomes, which Is mediated by the viral E2 protein and its binding sites. J Virol. 73:4404-12.
44. Ishizaka, Y., M.V. Chernov, C.M. Burns, and G.R. Stark. 1995. p53-dependent growth arrest of REF52 cells containing newly amplified DNA. Proc Natl Acad Sci U S A. 92:3224-8.
45. Itoh, N., and N. Shimizu. 1998. DNA replication-dependent intranuclear relocation of double minute chromatin. J Cell Sci. 111 ( Pt 22):3275-85.
46. Jasin, M. 1996. Genetic manipulation of genomes with rare-cutting endonucleases. Trends Genet. 12:224-8.
47. Jenke, A.C., I.M. Stehle, F. Herrmann, T. Eisenberger, A. Baiker, J. Bode, F.O. Fackelmayer, and H.J. Lipps. 2004. Nuclear scaffold/matrix attached region modules linked to a transcription unit are sufficient for replication and maintenance of a mammalian episome. Proc Natl Acad Sci U S A. 101:11322-7.
48. Kanda, T., M. Otter, and G.M. Wahl. 2001. Coupling of mitotic chromosome tethering and replication competence in epstein-barr virus-based plasmids. Mol Cell Biol. 21:3576-88.
49. Kaufman, R.J., P.C. Brown, and R.T. Schimke. 1979. Amplified dihydrofolate reductase genes in unstable methotrexate-resistant cells are associated with double minute chromosomes. Proc. Natl. Acad. Sci. USA. 76:5669-5673.
50. Knuutila, S., A.M. Bjorkqvist, K. Autio, M. Tarkkanen, M. Wolf, O. Monni, J. Szymanska, M.L. Larramendy, J. Tapper, H. Pere, W. El-Rifai, S. Hemmer, V.M. Wasenius, V. Vidgren, and Y. Zhu. 1998. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am. J. Pathol. 152:1107-23.
51. Kuo, M.T., R.C. Vyas, L.X. Jiang, and W.N. Hittelman. 1994. Chromosome breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells. Mol. Cell. Biol. 14:5202-11.
52. Kuwahara, Y., C. Tanabe, T. Ikeuchi, K. Aoyagi, M. Nishigaki, H. Sakamoto, K. Hoshinaga, T. Yoshida, H. Sasaki, and M. Terada. 2004. Alternative mechanisms of gene amplification in human cancers. Genes Chromosomes Cancer. 41:125-32.
53. Lafage, M., F. Pedeutour, S. Marchetto, J. Simonetti, M.T. Prosperi, P. Gaudray, and D. Birnbaum. 1992. Fusion and amplification of two originally non-syntenic chromosomal regions in a mammary carcinoma cell line. Genes Chromosomes and Cancer. 5:40-9.
54. Leo, C., A.J. Giaccia, and N.C. Denko. 2004. The hypoxic tumour microenvironment and gene expression. Semin Radiat Oncol. 14:207-14.
55. Lese, C.M., K.M. Rossie, B.N. Appel, J.K. Reddy, J.T. Johnson, E.N. Myers, and S.M. Gollin. 1995. Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas. Genes Chromosomes Cancer. 12:288-95.
56. Livingstone, L.R., A. White, J. Sprouse, E. Livanos, T. Jacks, and T.D. Tlsty. 1992. Cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell. 70:923-935.
57. Londono-Vallejo, J.A. 2004. Telomere length heterogeneity and chromosome instability. Cancer Lett. 212:135-44.
58. Luk, C.K., L. Veinot-Drebot, E. Tjan, and I.F. Tannock. 1990. Effect of transient hypoxia on sensitivity to doxorubicin in human and murine cell lines. J. Natl. Cancer Inst. 82:684-92.
59. Ma, C., S. Martin, B. Trask, and J.L. Hamlin. 1993. Sister chromatid fusion initiates amplification of the dihydrofolate reductase gene in Chinese hamster cells. Genes Dev. 7:605-20.
60. Maser, R.S., and R.A. DePinho. 2004. Telomeres and the DNA damage response: why the fox is guarding the henhouse. DNA Repair (Amst). 3:979-88.
61. Maurer, B.J., E. Lai, B.A. Hamkalo, L. Hood, and G. Attardi. 1987. Novel submicroscopic extrachromosomic elements containing amplified genes in human cells. Nature. 327:434-437.
62. McClintock, B. 1951. Chromosome organization and genic expression. Cold Spring Harbor Symp. Quant. Biol. 16:13-47.
63. Mondello, C., P. Rebuzzini, M. Dolzan, S. Edmonson, G.E. Taccioli, and E. Giulotto. 2001. Increased gene amplification in immortal rodent cells deficient for the DNA-dependent protein kinase catalytic subunit. Cancer Res. 61:4520-5.
64. Muleris, M., A. Almeida, M. Gerbault-Seureau, B. Malfoy, and B. Dutrillaux. 1995. Identification of amplified DNA sequences in breast cancer and their organization within homogeneously staining regions. Genes, Chromosomes & Cancer. 14:155-63.
65. Nonet, G.H., S.M. Carroll, M.L. DeRose, and G.M. Wahl. 1993. Molecular dissection of an extrachromosomal amplicon reveals a circular structure consisting of an imperfect inverted duplication. Genomics. 15:543-58.
66. O'Hagan, R.C., S. Chang, R.S. Maser, R. Mohan, S.E. Artandi, L. Chin, and R.A. DePinho. 2002. Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell. 2:149-55.
67. O'Sullivan, J.N., M.P. Bronner, T.A. Brentnall, J.C. Finley, W.T. Shen, S. Emerson, M.J. Emond, K.A. Gollahon, A.H. Moskovitz, D.A. Crispin, J.D. Potter, and P.S. Rabinovitch. 2002. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet. 32:280-4.
68. Okuno, Y., P.J. Hahn, and D.M. Gilbert. 2004. Structure of a palindromic amplicon junction implicates microhomology-mediated end joining as a mechanism of sister chromatid fusion during gene amplification. Nucleic Acids Res. 32:749-56.
69. Ormandy, C.J., E.A. Musgrove, R. Hui, R.J. Daly, and R.L. Sutherland. 2003. Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat. 78:323-35.
70. Paulson, T.G., A. Almasan, L.L. Brody, and G.M. Wahl. 1998. Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage. Mol Cell Biol. 18:3089-100.
71. Pedeutour, F., R.F. Suijkerbuijk, A. Forus, J. Van Gaal, W. Van de Klundert, J.M. Coindre, G. Nicolo, F. Collin, U. Van Haelst, K. Huffermann, and et al. 1994. Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma. Genes Chromosomes Cancer. 10:85-94.
72. Pipiras, E., A. Coquelle, A. Bieth, and M. Debatisse. 1998. Interstitial deletions and intrachromosomal amplification initiated from a double-strand break targeted to a mammalian chromosome. EMBO J. 17:325-333.
73. Popescu, N.C. 2003. Genetic alterations in cancer as a result of breakage at fragile sites. Cancer Lett. 192:1-17.
74. Poupon, M.F., K.A. Smith, O.B. Chernova, C. Gilbert, and G.R. Stark. 1996. Inefficient growth arrest in response to dNTP starvation stimulates gene amplification through bridge-breakage-fusion cycles. Mol. Biol. Cell. 7:345-354.
75. Raymond, E., S. Faivre, G. Weiss, J. McGill, K. Davidson, E. Izbicka, J.G. Kuhn, C. Allred, G.M. Clark, and D.D. Von Hoff. 2001. Effects of hydroxyurea on extrachromosomal DNA in patients with advanced ovarian carcinomas. Clin Cancer Res. 7:1171-80.
76. Rice, G.C., C. Hoy, and R.T. Schimke. 1986. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA. 83:5978-5982.
77. Richards, R.I. 2001. Fragile and unstable chromosomes in cancer: causes and consequences. Trends Genet. 17:339-45.
78. Roelofs, H., E. Schuuring, J. Wiegant, R. Michalides, and M. Giphart-Gassler. 1993. Amplification of the 11q13 region in human carcinoma cell lines: a mechanistic view. Genes Chromosomes Cancer. 7:74-84.
79. Saunders, W.S., M. Shuster, X. Huang, B. Gharaibeh, A.H. Enyenihi, I. Petersen, and S.M. Gollin. 2000. Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci U S A. 97:303-8.
80. Schoenlein, P.V., J.T. Barrett, A. Kulharya, M.R. Dohn, A. Sanchez, D.Y. Hou, and J. McCoy. 2003. Radiation therapy depletes extrachromosomally amplified drug resistance genes and oncogenes from tumour cells via micronuclear capture of episomes and double minute chromosomes. Int J Radiat Oncol Biol Phys. 55:1051-65.
81. Schwab, M. 1999. Oncogene amplification in solid tumours. Semin. cancer Biol. 9:319-325.
82. Schwab, M. 2004. MYCN in neuronal tumours. Cancer Lett. 204:179-87.
83. Schwab, M., and L.C. Amler. 1990. Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer. Genes Chromosomes Cancer. 1:181-193.
84. Sharpless, N.E., D.O. Ferguson, R.C. O'Hagan, D.H. Castrillon, C. Lee, P.A. Farazi, S. Alson, J. Fleming, C.C. Morton, K. Frank, L. Chin, F.W. Alt, and R.A. DePinho. 2001. Impaired nonhomologous end-joining provokes soft tissue sarcomas harbouring chromosomal translocations, amplifications, and deletions. Mol Cell. 8:1187-96.
85. Shimizu, N., T. Hashizume, K. Shingaki, and J.K. Kawamoto. 2003. Amplification of plasmids containing a mammalian replication initiation region is mediated by controllable conflict between replication and transcription. Cancer Res. 63:5281-90.
86. Shimizu, N., N. Itoh, H. Utiyama, and G.M. Wahl. 1998. Selective entrapment of extrachromosomally amplified DNA by nuclear budding and micronucleation during S phase. 1998. 140:1307-1320.
87. Shimizu, N., Y. Miura, Y. Sakamoto, and K. Tsutsui. 2001. Plasmids with a mammalian replication origin and a matrix attachment region initiate the event similar to gene amplification. Cancer Res. 61:6987-90.
88. Shuster, M.I., L. Han, M.M. Le Beau, E. Davis, M. Sawicki, C.M. Lese, N.H. Park, J. Colicelli, and S.M. Gollin. 2000. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification. Genes Chromosomes Cancer. 28:153-63.
89. Sinclair, C.S., M. Rowley, A. Naderi, and F.J. Couch. 2003. The 17q23 amplicon and breast cancer. Breast Cancer Res Treat. 78:313-22.
90. Singer, M.J., L.D. Mesner, C.L. Friedman, B.J. Trask, and J.L. Hamlin. 2000. Amplification of the human dihydrofolate reductase gene via double minutes is initiated by chromosome breaks. Proc Natl Acad Sci U S A. 97:7921-6.
91. Smith, D.I., H. Huang, and L. Wang. 1998. Common fragile sites and cancer. International Journal of Oncology. 12:187-196.
92. Smith, K.A., P.A. Gorman, M.B. Stark, R.P. Groves, and G.R. Stark. 1990. Distinctive chromosomal structures are formed very early in the amplification of CAD genes in Syrian hamster cells. Cell. 63:1219-1227.
93. Smith, K.A., M.B. Stark, P.A. Gorman, and G.R. Stark. 1992. Fusion near telomeres occur very early in the amplification of CAD genes in Syrian hamster cells. Proc. Natl. Acad. Sci. U.S.A. 89:5427-5431.
94. Stark, G.R., and G.M. Wahl. 1984. Gene amplification. Ann. Rev. Biochem. 53:447-491.
95. Storlazzi, C.T., T. Fioretos, K. Paulsson, B. Strombeck, C. Lassen, T. Ahlgren, G. Juliusson, F. Mitelman, M. Rocchi, and B. Johansson. 2004. Identification of a commonly amplified 4.3 Mb region with overexpression of C8FW, but not MYC in MYC-containing double minutes in myeloid malignancies. Hum Mol Genet. 13:1479-85.
96. Sutherland, G.R., E. Baker, and R.I. Richards. 1998. Fragile Sites Still Breaking. Trends in Genetics. 14:501-506.
97. Tanaka, T., and N. Shimizu. 2000. Induced detachment of acentric chromatin from mitotic chromosomes leads to their cytoplasmic localization at G(1) and the micronucleation by lamin reorganization at S phase. J Cell Sci. 113 (Pt 4):697-707.
98. Thomas, L., J. Stamberg, I. Gojo, Y. Ning, and A.P. Rapoport. 2004. Double minute chromosomes in monoblastic (M5) and myeloblastic (M2) acute myeloid leukemia: two case reports and a review of literature. Am J Hematol. 77:55-61.
99. Toledo, F., G. Buttin, and M. Debatisse. 1993. The origin of chromosome rearrangements at early stages of AMPD2 gene amplification in Chinese hamster cells. Current Biol. 3:255-264.
100. Toledo, F., D. LeRoscouet, G. Buttin, and M. Debatisse. 1992b. Co-amplified markers alternate in megabase long chromosomal inverted repeats and cluster independently in interphase nuclei at early steps of mammalian gene amplification. EMBO J. 11:2665-2673.
101. Toledo, F., K.A. Smith, G. Buttin, and M. Debatisse. 1992a. The evolution of the amplified adenylate-deaminase-2 domains in Chinese hamster cells suggests the sequential intervention of different mechanisms of DNA amplification. Mutation Res. 276:261-273.
102. Vogt, N., S.H. Lefevre, F. Apiou, A.M. Dutrillaux, A. Cor, P. Leuraud, M.F. Poupon, B. Dutrillaux, M. Debatisse, and B. Malfoy. 2004. Molecular structure of double-minute chromosomes bearing amplified copies of the epidermal growth factor receptor gene in gliomas. Proc Natl Acad Sci U S A. 101:11368-73.
103. Wahl, G.M. 1989. The importance of circular DNA in mammalian gene amplification. Cancer Res. 49:1333-1340.
104. Windle, B., B.W. Draper, Y. Yin, S. O'Gorman, and G.M. Wahl. 1991. A central role for chromosome breakage in gene amplification, deletion formation and amplicon integration. Genes Dev. 5:160-174.
105. Windle, B.E., and G.M. Wahl. 1992. Molecular dissection of mammalian gene amplification: new mechanistic insights revealed by analyses of very early events. Mutat Res. 276:199-224.
106. Yin, Y., M.A. Tainsky, F.Z. Bischoff, L.C. Strong, and G.M. Wahl. 1992. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell. 70:937-948.
107. Zhu, C., K.D. Mills, D.O. Ferguson, C. Lee, J. Manis, J. Fleming, Y. Gao, C.C. Morton, and F.W. Alt. 2002. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell. 109:811-21.